CINTHYA MARQUEZ LOBOS: Open Payments
NPI 1649044736 · LEDERACH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,811 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $230 |
| AstraZeneca Pharmaceuticals LP | 4 | $168 |
| Lilly USA, LLC | 4 | $160 |
| Amgen Inc. | 4 | $155 |
| ABBVIE INC. | 2 | $125 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Abbott Laboratories | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: Wegovy, EVENITY, QULIPTA, ZEPBOUND, BREZTRI, AIRSUPRA, SHINGRIX, MOUNJARO.
Industry payments across PA — which companies pay providers there.
